Multi-institutional study of ‘Sandwich treatment’ for motor area large brain metastases (LBM) with diameter over 3 cm

1. Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study. Neuro Oncol 20217; 19: 1511–21. doi: 10.1093/neuonc/nox077 CagneyDN MartinAM CatalanoPJ RedigAJ LinNU LeeEQ Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study Neuro Oncol 2017 19 1511 21 10.1093/neuonc/nox077 Open DOISearch in Google Scholar

2. Graber JJ, Cobbs CS, Olson JJ. Congress of neurological surgeons systematic review and evidence-based guidelines on the use of stereotactic radiosurgery in the treatment of adults with metastatic brain tumors. Neurosurgery 2019; 84: E168–E170. doi: 10.1093/neuros/nyy543 GraberJJ CobbsCS OlsonJJ Congress of neurological surgeons systematic review and evidence-based guidelines on the use of stereotactic radiosurgery in the treatment of adults with metastatic brain tumors Neurosurgery 2019 84 E168 E170 10.1093/neuros/nyy543 Open DOISearch in Google Scholar

3. Han JH, Kim DG, Chung HT, Paek SH, Park CK, Jung HW. Radiosurgery for large brain metastases. Int J Radiat Oncol Biol Phys 2012; 83: 113–20. doi: 10.1016/j.ijrobp.2011.06.1965 HanJH KimDG ChungHT PaekSH ParkCK JungHW Radiosurgery for large brain metastases Int J Radiat Oncol Biol Phys 2012 83 113 20 10.1016/j.ijrobp.2011.06.1965 Open DOISearch in Google Scholar

4. Arvold ND, Lee EQ, Mehta MP, Margolin K, Alexander BM, Lin NU, et al. Updates in the management of brain metastases 2016; Neuro Oncol 2016; 18: 1043–65. doi: 10.1093/neuonc/now127 ArvoldND LeeEQ MehtaMP MargolinK AlexanderBM LinNU Updates in the management of brain metastases 2016 Neuro Oncol 2016 18 1043 65 10.1093/neuonc/now127 Open DOISearch in Google Scholar

5. Devoid HM, McTyre ER, Page BR, Metheny-Barlow L, Ruiz J, Chan MD. Recent advances in radiosurgical management of brain metastases. Front Biosci 2016; 8: 203–14. doi: 10.2741/s458 DevoidHM McTyreER PageBR Metheny-BarlowL RuizJ ChanMD Recent advances in radiosurgical management of brain metastases Front Biosci 2016 8 203 14 10.2741/s458 Open DOISearch in Google Scholar

6. Milano MT, Chiang VLS, Soltys SG, Wang TJC, Lo SS, Brackett, et al. Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases. Neuro Oncol 2020; 22: 1728–41. doi: 10.1093/neuonc/noaa192 MilanoMT ChiangVLS SoltysSG WangTJC LoSS Brackett Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases Neuro Oncol 2020 22 1728 41 10.1093/neuonc/noaa192 Open DOISearch in Google Scholar

7. Hasegawa T, Kato T, Yamamoto T, Iizuka H, Nishikawa T, Ito H, et al. Multisession gamma knife surgery for large brain metastases. J Neurooncol 2017; 131: 517–24. doi: 10.1007/s11060-016-2317-4 HasegawaT KatoT YamamotoT IizukaH NishikawaT ItoH Multisession gamma knife surgery for large brain metastases J Neurooncol 2017 131 517 24 10.1007/s11060-016-2317-4 Open DOISearch in Google Scholar

8. Dohm AE, Hughes R, Wheless W, Lecompte M, Lanier C, Ruiz J. Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases. J Neurooncol 2018; 140: 749–56. doi: 10.1007/s11060-018-03008-8 DohmAE HughesR WhelessW LecompteM LanierC RuizJ Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases J Neurooncol 2018 140 749 56 10.1007/s11060-018-03008-8 Open DOISearch in Google Scholar

9. Yomo S, Hayashi M, Nicholson C. A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors. J Neurooncol 2012; 109: 159–65. doi: 10.1007/s11060-012-0882-8 YomoS HayashiM NicholsonC A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors J Neurooncol 2012 109 159 65 10.1007/s11060-012-0882-8 Open DOISearch in Google Scholar

10. Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST, et al. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm. J Neurosurg 2018; 129: 366–82. doi: 10.3171/2017.3.JNS162532 AngelovL MohammadiAM BennettEE AbbassyM ElsonP ChaoST Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm J Neurosurg 2018 129 366 82 10.3171/2017.3.JNS162532 Open DOISearch in Google Scholar

11. Serizawa T, Higuchi Y, Yamamoto M, Matsunaga S, Nagano O, Sato Y, et al. Comparison of treatment results between 3- And 2-stage Gamma Knife radiosurgery for large brain metastases: A retrospective multi-institutional study. J Neurosurg 2018; 131: 227–37. doi: 10.3171/2018.4.JNS172596 SerizawaT HiguchiY YamamotoM MatsunagaS NaganoO SatoY Comparison of treatment results between 3- And 2-stage Gamma Knife radiosurgery for large brain metastases: A retrospective multi-institutional study J Neurosurg 2018 131 227 37 10.3171/2018.4.JNS172596 Open DOISearch in Google Scholar

12. Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 2022; 40: 492–516. doi: 10.1200/JCO.21.02314 VogelbaumMA BrownPD MessersmithH BrastianosPK BurriS CahillD Treatment for brain metastases: ASCO-SNO-ASTRO guideline J Clin Oncol 2022 40 492 516 10.1200/JCO.21.02314 Open DOISearch in Google Scholar

13. Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, et al. Single versus multifraction stereotactic radiosurgery for large brain metastases: An international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 2019; 103: 618–30. doi: 10.1016/j.ijrobp.2018.10.038 LehrerEJ PetersonJL ZaorskyNG BrownPD SahgalA ChiangVL Single versus multifraction stereotactic radiosurgery for large brain metastases: An international meta-analysis of 24 trials Int J Radiat Oncol Biol Phys 2019 103 618 30 10.1016/j.ijrobp.2018.10.038 Open DOISearch in Google Scholar

14. Pintea B, Baumert B, Kinfe TM, Gousias K, Parpaley Y, Boström JP. Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: A retrospective study of two consecutive cohorts. Radiat Oncol 2017; 12: 177. doi: 10.1186/s13014-017-0917-6 PinteaB BaumertB KinfeTM GousiasK ParpaleyY BoströmJP Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: A retrospective study of two consecutive cohorts Radiat Oncol 2017 12 177 10.1186/s13014-017-0917-6 Open DOISearch in Google Scholar

15. Loganadane G, Dhermain F, Louvel G, Kauv P, Deutsch E, Le Péchoux C, et al. Brain radiation necrosis: Current management with a focus on non-small cell lung cancer patients. Front Oncol 2018; 8: 336. doi: 10.3389/fonc.2018.00336 LoganadaneG DhermainF LouvelG KauvP DeutschE Le PéchouxC Brain radiation necrosis: Current management with a focus on non-small cell lung cancer patients Front Oncol 2018 8 336 10.3389/fonc.2018.00336 Open DOISearch in Google Scholar

16. Miller JA, Bennett EE, Xiao R, Kotecha R, Chao ST, Vogelbaum MA, et al. Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis. Int J Radiat Oncol Biol Phys 2016; 96: 1060–9. doi: 10.1016/j.ijrobp.2016.08.039 MillerJA BennettEE XiaoR KotechaR ChaoST VogelbaumMA Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis Int J Radiat Oncol Biol Phys 2016 96 1060 9 10.1016/j.ijrobp.2016.08.039 Open DOISearch in Google Scholar

17. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96: 45–68. doi: 10.1007/s11060-009-0073-4 LinskeyME AndrewsDW AsherAL BurriSH KondziolkaD RobinsonPD The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline J Neurooncol 2010 96 45 68 10.1007/s11060-009-0073-4 Open DOISearch in Google Scholar

18. Desai B, Rassam D, Ezeh P, et al. Phase III trial of PF-06439535 or bevacizumab-eu plus paclitaxel/carboplatin in NSCLC. J Thorac Oncol 2015; 10: S665. DesaiB RassamD EzehP Phase III trial of PF-06439535 or bevacizumab-eu plus paclitaxel/carboplatin in NSCLC J Thorac Oncol 2015 10 S665 Search in Google Scholar

19. Tamura R, Tanaka T, Miyake K, Yoshida K, Sasaki H. Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response. Brain Tumor Pathol 2017; 34: 62–77. doi: 10.1007/s10014-017-0284-x TamuraR TanakaT MiyakeK YoshidaK SasakiH Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response Brain Tumor Pathol 2017 34 62 77 10.1007/s10014-017-0284-x Open DOISearch in Google Scholar

20. Lubelski D, Abdullah KG, Weil RJ, Marko NF. Bevacizumab for radiation necrosis following treatment of high grade glioma: A systematic review of the literature. J Neurooncol 2013; 115: 317–22. doi: 10.1007/s11060-013-1233-0 LubelskiD AbdullahKG WeilRJ MarkoNF Bevacizumab for radiation necrosis following treatment of high grade glioma: A systematic review of the literature J Neurooncol 2013 115 317 22 10.1007/s11060-013-1233-0 Open DOISearch in Google Scholar

21. Delishaj D, Ursino S, Pasqualetti F, Cristaudo A, Cosottini M, Fabrini MG, et al. Bevacizumab for the treatment of radiation-induced cerebral necrosis: A systematic review of the literature. J Clin Med Res 2017; 9: 273–80. doi: 10.14740/jocmr2936e DelishajD UrsinoS PasqualettiF CristaudoA CosottiniM FabriniMG Bevacizumab for the treatment of radiation-induced cerebral necrosis: A systematic review of the literature J Clin Med Res 2017 9 273 80 10.14740/jocmr2936e Open DOISearch in Google Scholar

22. Alanin MC, Klausen C, Caye-Thomasen P, Thomsen C, Fugleholm K, Poulsgaard L, et al. Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 – a retrospective case series. Int J Neurosci 2016; 126: 1002–6. doi: 10.3109/00207454.2015.1092443 AlaninMC KlausenC Caye-ThomasenP ThomsenC FugleholmK PoulsgaardL Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 – a retrospective case series Int J Neurosci 2016 126 1002 6 10.3109/00207454.2015.1092443 Open DOISearch in Google Scholar

23. Hawasli AH, Rubin JB, Tran DD, Adkins DR, Waheed S, Hullar TE, et al. Antiangiogenic agents for nonmalignant brain tumors. J Neurol Surg B Skull Base 2013; 74: 136–41. doi: 10.1055/s-0033-1338262 HawasliAH RubinJB TranDD AdkinsDR WaheedS HullarTE Antiangiogenic agents for nonmalignant brain tumors J Neurol Surg B Skull Base 2013 74 136 41 10.1055/s-0033-1338262 Open DOISearch in Google Scholar

24. Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, et al. Response assessment criteria for brain metastases: Proposal from the RANO group. Lancet Oncol 2015; 16: e270–e8. doi: 10.1016/S1470-2045(15)70057-4 LinNU LeeEQ AoyamaH BaraniIJ BarboriakDP BaumertBG Response assessment criteria for brain metastases: Proposal from the RANO group Lancet Oncol 2015 16 e270 e8 10.1016/S1470-2045(15)70057-4 Open DOISearch in Google Scholar

25. Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 2010, 66: 486–91. doi: 10.1227/01.NEU.0000360391.35749.A5 KanoH KondziolkaD Lobato-PoloJ ZorroO FlickingerJC LunsfordLD T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery Neurosurgery 2010 66 486 91 10.1227/01.NEU.0000360391.35749.A5 Open DOISearch in Google Scholar

26. Minamimoto R, Saginoya T, Kondo C, Tomura N, Ito K, Matsuo Y, et al. Differentiation of brain tumor recurrence from post-radiotherapy necrosis with ¹¹C-methionine PET: Visual assessment versus quantitative assessment. PLoS One 2015; 10: e0132515. doi: 10.1371/journal.pone.0132515 MinamimotoR SaginoyaT KondoC TomuraN ItoK MatsuoY Differentiation of brain tumor recurrence from post-radiotherapy necrosis with ¹¹C-methionine PET: Visual assessment versus quantitative assessment PLoS One 2015 10 e0132515 10.1371/journal.pone.0132515 Open DOISearch in Google Scholar

27. Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 2008; 40: 665–71. doi: 10.2340/16501977-0235 Paternostro-SlugaT Grim-StiegerM PoschM SchuhfriedO VacariuG MittermaierC Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy J Rehabil Med 2008 40 665 71 10.2340/16501977-0235 Open DOISearch in Google Scholar

28. Hankemeier A, Rollnik JD. The Early Functional Abilities (EFA) scale to assess neurological and neurosurgical early rehabilitation patients. BMC Neurol 2015; 15: 207. doi: 10.1186/s12883-015-0469-z HankemeierA RollnikJD The Early Functional Abilities (EFA) scale to assess neurological and neurosurgical early rehabilitation patients BMC Neurol 2015 15 207 10.1186/s12883-015-0469-z Open DOISearch in Google Scholar

29. Yomo S, Hayashi M. A minimally invasive treatment option for large metastatic brain tumors: Long-term results of two-session Gamma Knife stereotactic radiosurgery. Radiat Oncol 2014; 9: 132. doi: 10.1186/1748-717X-9-132 YomoS HayashiM A minimally invasive treatment option for large metastatic brain tumors: Long-term results of two-session Gamma Knife stereotactic radiosurgery Radiat Oncol 2014 9 132 10.1186/1748-717X-9-132 Open DOISearch in Google Scholar

30. Damron EP, Dono A, Chafi H, Martir M, Yu TK, Khwaja S, et al. Metastatic neoplasm volume kinetics following 2-stage stereotactic radiosurgery. World Neurosurg 2022; 161: e210–e9. doi: 10.1016/j.wneu.2022.01.109 DamronEP DonoA ChafiH MartirM YuTK KhwajaS Metastatic neoplasm volume kinetics following 2-stage stereotactic radiosurgery World Neurosurg 2022 161 e210 e9 10.1016/j.wneu.2022.01.109 Open DOISearch in Google Scholar

31. Hori Y, Muhsen B, Joshi K, Wei W, Borghei-Razavi H, Chao S et al. The efficacy and safety of two-staged stereotactic radiosurgery for large posterior fossa metastases: post-treatment volumetric changes in tumor size, peri-tumoral edema, and fourth ventricle. Neuro Oncol 2020; 22 Suppl2: ii181. doi: 10.1093/neuonc/noaa215.756 HoriY MuhsenB JoshiK WeiW Borghei-RazaviH ChaoS The efficacy and safety of two-staged stereotactic radiosurgery for large posterior fossa metastases: post-treatment volumetric changes in tumor size, peri-tumoral edema, and fourth ventricle Neuro Oncol 2020 22 Suppl2 ii181 10.1093/neuonc/noaa215.756 Open DOISearch in Google Scholar

32. Ito D, Aoyagi K, Nagano O, Serizawa T, Iwadate Y, Higuchi Y. Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers. J Neurooncol 2020; 147: 237–46. doi: 10.1007/s11060-020-03421-y ItoD AoyagiK NaganoO SerizawaT IwadateY HiguchiY Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers J Neurooncol 2020 147 237 46 10.1007/s11060-020-03421-y Open DOISearch in Google Scholar

33. Cho A, Medvedeva K, Kranawetter B, Untersteiner H, Hirschmann D, Lepilina O, et al. How to dose-stage large or high-risk brain metastases: an alternative two-fraction radiosurgical treatment approach. J Neurosurg 2022; 137: 1666–75. doi: 10.3171/2022.2.JNS212440 ChoA MedvedevaK KranawetterB UntersteinerH HirschmannD LepilinaO How to dose-stage large or high-risk brain metastases: an alternative two-fraction radiosurgical treatment approach J Neurosurg 2022 137 1666 75 10.3171/2022.2.JNS212440 Open DOISearch in Google Scholar

34. Li J, He J, Cai L, Lai M, Hu Q, Ren C, et al. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts. Ann Palliat Med 2021; 10: 2018–26. doi: 10.21037/apm-20-2417 LiJ HeJ CaiL LaiM HuQ RenC Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts Ann Palliat Med 2021 10 2018 26 10.21037/apm-20-2417 Open DOISearch in Google Scholar

35. Erpolat OP, Demircan NV, Sarıbas GS, Kuzucu P, Senturk E, Elmas C, et al. A comparison of Ramipril and Bevacizumab to mitigate radiation-induced brain necrosis: An experimental study. World Neurosurg 2020; 144: e210–e20. doi: 10.1016/j.wneu.2020.08.081 ErpolatOP DemircanNV SarıbasGS KuzucuP SenturkE ElmasC A comparison of Ramipril and Bevacizumab to mitigate radiation-induced brain necrosis: An experimental study World Neurosurg 2020 144 e210 e20 10.1016/j.wneu.2020.08.081 Open DOISearch in Google Scholar

36. Ai B, Zhang L, Huang D, Chen J, Liu Z, Hu X, et al. Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study. Thorac Cancer 2020; 11: 3641–4. doi: 10.1111/1759-7714.13687 AiB ZhangL HuangD ChenJ LiuZ HuX Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study Thorac Cancer 2020 11 3641 4 10.1111/1759-7714.13687 Open DOISearch in Google Scholar